Skip to content
Axcess News – Lifestyle
Author:
Tectonic Therapeutic
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
June 10, 2026
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
April 23, 2026
Tectonic Therapeutic to Participate in March Investor Conferences
March 6, 2026
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 6, 2026
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
March 5, 2026